{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:07:07Z","timestamp":1779278827257,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"DOI":"10.1007\/s00392-026-02941-3","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:26:31Z","timestamp":1779276391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Telepharmacy-supported multidisciplinary management and clinical outcomes in patients with transthyretin amyloid cardiomyopathy treated with tafamidis: a real-world study"],"prefix":"10.1007","author":[{"given":"L.","family":"Cordiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Condello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Chinellato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mengato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bucciol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Nistor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Poliseno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pivato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sinigiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"De Michieli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"9","key":"2941_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2589","volume":"24","author":"AS Antonopoulos","year":"2022","unstructured":"Antonopoulos AS, Panagiotopoulos I, Kouroutzoglou A et al (2022) Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis. Eur J Heart Fail 24(9):1677. https:\/\/doi.org\/10.1002\/ejhf.2589","journal-title":"Eur J Heart Fail"},{"key":"2941_CR2","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B et al (2018) Tafamidis treatment for transthyretin amyloid cardiomyopathy. N Engl J Med 379:1007. https:\/\/doi.org\/10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"},{"issue":"4","key":"2941_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK (2011) Medication adherence: WHO cares? Mayo Clin Proc 86(4):304\u2013314. https:\/\/doi.org\/10.4065\/mcp.2010.0575","journal-title":"Mayo Clin Proc"},{"key":"2941_CR4","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1093\/pubmed\/fdy088","volume":"41","author":"KH Leslie","year":"2019","unstructured":"Leslie KH, McCowan C, Pell JP (2019) Adherence to cardiovascular medication: a review of systematic reviews. J Public Health (Oxf) 41:e84\u2013e94. https:\/\/doi.org\/10.1093\/pubmed\/fdy088","journal-title":"J Public Health (Oxf)"},{"issue":"11","key":"2941_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000011.pub4","volume":"2014","author":"R Nieuwlaat","year":"2014","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T et al (2014) Interventions for enhancing medication adherence. Cochrane Database Syst Rev (11):CD000011. https:\/\/doi.org\/10.1002\/14651858.CD000011.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2941_CR6","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D479","volume":"38","author":"J George","year":"2004","unstructured":"George J, Phun YT, Bailey MJ et al (2004) Development and validation of the medication regimen complexity index. Ann Pharmacother 38:1369. https:\/\/doi.org\/10.1345\/aph.1D479","journal-title":"Ann Pharmacother"},{"key":"2941_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/jcpt.12753","volume":"44","author":"JA Manski-Nankervis","year":"2019","unstructured":"Manski-Nankervis JA, Thuraisingam S, Patterson J et al (2019) Impact of medication regimen complexity in primary care. J Clin Pharm Ther 44:924. https:\/\/doi.org\/10.1111\/jcpt.12753","journal-title":"J Clin Pharm Ther"},{"key":"2941_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/phar.1313","volume":"33","author":"AM Libby","year":"2013","unstructured":"Libby AM, Fish DN, Hosokawa PW et al (2013) Patient-level medication regimen complexity and pharmacy costs. Pharmacotherapy 33:1077. https:\/\/doi.org\/10.1002\/phar.1313","journal-title":"Pharmacotherapy"},{"key":"2941_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1706056","volume":"16","author":"D Mengato","year":"2025","unstructured":"Mengato D, Camuffo L, Todino F et al (2025) Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experience. Front Pharmacol 16:1706056. https:\/\/doi.org\/10.3389\/fphar.2025.1706056","journal-title":"Front Pharmacol"},{"issue":"8","key":"2941_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2025.102549","volume":"13","author":"G Sinigiani","year":"2025","unstructured":"Sinigiani G, Sanna GD, Aimo A et al (2025) Outcome and disease progression in NYHA functional class I and II patients with wild-type transthyretin cardiomyopathy treated with tafamidis. JACC Heart Fail 13(8):102549. https:\/\/doi.org\/10.1016\/j.jchf.2025.102549","journal-title":"JACC Heart Fail"},{"issue":"10","key":"2941_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14103481","volume":"14","author":"L De Michieli","year":"2025","unstructured":"De Michieli L, Lupi A, Sinigiani G et al (2025) Pharmacological management of transthyretin amyloid cardiomyopathy: where we are and where we are going. J Clin Med 14(10):3481. https:\/\/doi.org\/10.3390\/jcm14103481","journal-title":"J Clin Med"},{"key":"2941_CR12","unstructured":"Italian Medicines Agency. AIFA monitoring registers. Accessed 15 Mar 2026.\u00a0https:\/\/www.aifa.gov.it\/en\/registri-farmaci-sottoposti-a-monitoraggio"},{"issue":"4","key":"2941_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.1771","volume":"6","author":"KK Shah","year":"2023","unstructured":"Shah KK, Touchette DR, Marrs JC (2023) Research and scholarly methods: measuring medication adherence. J Am Coll Clin Pharm 6(4):416. https:\/\/doi.org\/10.1002\/jac5.1771","journal-title":"J Am Coll Clin Pharm"},{"issue":"10","key":"2941_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5490","volume":"31","author":"L Rasmussen","year":"2022","unstructured":"Rasmussen L, Wettermark B, Steinke D, Potteg\u00e5rd A (2022) Core concepts in pharmacoepidemiology: measures of drug utilization based on individual-level drug dispensing data. Pharmacoepidemiol Drug Saf 31(10):1015. https:\/\/doi.org\/10.1002\/pds.5490","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02941-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-026-02941-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-026-02941-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:26:38Z","timestamp":1779276398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-026-02941-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":14,"alternative-id":["2941"],"URL":"https:\/\/doi.org\/10.1007\/s00392-026-02941-3","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"20 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to local regulations and institutional policy, studies based exclusively on anonymized administrative and routine clinical data do not require formal ethics committee approval. The study was performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. No patient-identifiable information was used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable because this is a retrospective study based on anonymized administrative and clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}